Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin.
Dirschka
T
T
Department of Dermatology, Ruhr-University Bochum, Germany.
Kastner
U
U
Behrens
S
S
Altmeyer
P
P
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007871:Leg Ulcer / Q000188:drug therapy / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use; D017511:Pyoderma Gangrenosum / Q000188:drug therapy / Q000628:therapy*; D016896:Treatment Outcome; D014945:Wound Healing
D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone